Dr Gael MouterdeRhumatologue à Montpellier

Activité mixte

Appeler· 04 67 33 67 33 Rechercher sur Doctolib

Photo : Wolfgang Staudt from Saarbruecken, Germany, CC BY 2.0, Wikimedia Commons

Vous êtes Dr Gael Mouterde ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.

Configurer votre fiche gratuitement →

Dr Gael Mouterde est rhumatologue à Montpellier (34295). Il consulte notamment à CABINET PRIVE DU DR GAEL MOUTERDE, HOPITAL LAPEYRONIE CHU MONTPELLIER, OS ET ARTICULATIONS RHUMATOLOGIE — 371 AVENUE DU DOYEN GASTON GIRAUD, 34295 Montpellier (2 lieux au total). Il exerce en secteur 2 et accepte la carte Vitale.

Enregistrer le contact

publications: 48publications
citations: 2 026citations
lieux de consultation: 2lieux de consultation

Consulter

Lieux de consultation

CABINET PRIVE DU DR GAEL MOUTERDE
HOPITAL LAPEYRONIE CHU MONTPELLIER, OS ET ARTICULATIONS RHUMATOLOGIE — 371 AVENUE DU DOYEN GASTON GIRAUD, 34295 Montpellier

Dr Gael Mouterde, c'est vous ?

Faites de cette fiche la page de votre cabinet.

Votre présentationQuelques lignes sur votre pratique, affichées en tête de page.
Vos domaines d'expertiseLes pathologies que vous suivez, à la place des domaines déduits.
Vos actesÉchographie, infiltrations, viscosupplémentation, PRP, téléexpertise.
Vos liensSite du cabinet, LinkedIn, secteur de conventionnement corrigé.

Configurer votre fiche gratuitementGratuit · réservé au praticien

En bref

Questions fréquentes sur Dr Gael Mouterde

Où consulte Dr Gael Mouterde ?

Dr Gael Mouterde exerce dans 2 lieux : CABINET PRIVE DU DR GAEL MOUTERDE, HOPITAL LAPEYRONIE CHU MONTPELLIER, OS ET ARTICULATIONS RHUMATOLOGIE — 371 AVENUE DU DOYEN GASTON GIRAUD, 34295 Montpellier et HOPITAL LAPEYRONIE CHU MONTPELLIER, 371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier. Adresses issues de l'Annuaire Santé (ANS).

Comment prendre rendez-vous avec Dr Gael Mouterde ?

Par téléphone au 04 67 33 67 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.

Dr Gael Mouterde est-il conventionné ?

Oui, en secteur 2 (honoraires libres, dépassements possibles). Source : Assurance Maladie.

Dr Gael Mouterde accepte-t-il la carte Vitale ?

Oui. Source : Assurance Maladie.

D'où viennent les informations de cette page ?

Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.

Polyarthrite rhumatoïde · 22

2025The Lancet. RheumatologyPubMed

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

2024RMD openPubMed

Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study

2021Arthritis & rheumatology (Hoboken, N.J.)PubMed

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis

2021Joint bone spinePubMed

Recommendations for the pragmatic use of ultrasound in rheumatoid arthritis by the GEISPER French group

2020The Journal of rheumatologyPubMed

Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort

2019Rheumatology (Oxford, England)PubMed

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

2019RMD openPubMed

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients

2019Arthritis research & therapyPubMed

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort

2017Annals of the rheumatic diseasesPubMed

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

2016Clinical and experimental rheumatologyPubMed

Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study

2015Annals of the rheumatic diseasesPubMed

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

2014Joint bone spinePubMed

The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis

2013Joint bone spinePubMed

Improving agreement in assessment of synovitis in rheumatoid arthritis

2012La Revue du praticienPubMed

[Classification criteria for rheumatoid arthritis]

2012Clinical and experimental rheumatologyPubMed

Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies

2012The Journal of rheumatologyPubMed

Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials

2012Joint bone spinePubMed

Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI

2011Joint bone spinePubMed

Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review

2011Rheumatology (Oxford, England)PubMed

Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis

2010Joint bone spinePubMed

Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion

2010Joint bone spinePubMed

Use of glucocorticoids in rheumatoid arthritis - pratical modalities of glucocorticoid therapy: recommendations for clinical practice based on data from the literature and expert opinion

2007Joint bone spinePubMed

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis

CPPD · 6

2025The Journal of rheumatologyPubMed

Tradition Versus Innovation: Conventional Radiography and Ultrasound in Calcium Pyrophosphate Deposition Identification. Instructions for Use

2023The Lancet. RheumatologyPubMed

Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level

2023Arthritis & rheumatology (Hoboken, N.J.)PubMed

Reliability and Diagnostic Accuracy of Radiography for the Diagnosis of Calcium Pyrophosphate Deposition: Performance of the Novel Definitions Developed by an International Multidisciplinary Working Group

2021Annals of the rheumatic diseasesPubMed

Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study

Transversal · 5

2023RMD openPubMed

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

2022RMD openPubMed

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study

2014The Journal of rheumatologyPubMed

Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort

2011Annals of the rheumatic diseasesPubMed

Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis

Échographie · 4

2024RMD openPubMed

2023Rheumatology and therapyPubMed

Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort

2014Arthritis care & researchPubMed

Value of contrast-enhanced ultrasonography for the detection and quantification of enthesitis vascularization in patients with spondyloarthritis

2011Rheumatology (Oxford, England)PubMed

Rhumatisme psoriasique · 4

2026Rheumatology (Oxford, England)PubMed

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

2025Joint bone spinePubMed

Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

2023Seminars in arthritis and rheumatismPubMed

Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension

2014Annals of the rheumatic diseasesPubMed

Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials

Arthrite juvénile · 3

2023Rheumatology (Oxford, England)PubMed

JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

2023Rheumatology and therapyPubMed

Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort

2021Rheumatology (Oxford, England)PubMed

Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise

csDMARDs · 3

2026Rheumatology (Oxford, England)PubMed

One-month delay in MTX initiation on RA outcomes: 1-year ancillary analysis of the VACIMRA trial

2025The Lancet. RheumatologyPubMed

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

2011Joint bone spinePubMed

Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review

Goutte · 2

2020Joint bone spinePubMed

UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis

2019Rheumatology (Oxford, England)PubMed

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study

Sjögren · 2

2025Rheumatology (Oxford, England)PubMed

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

2024Rheumatology and therapyPubMed

Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training Initiative

Spondyloarthrite · 2

2023Seminars in arthritis and rheumatismPubMed

2014Arthritis care & researchPubMed

Value of contrast-enhanced ultrasonography for the detection and quantification of enthesitis vascularization in patients with spondyloarthritis

Anti-IL-17 · 1

2023Seminars in arthritis and rheumatismPubMed

Anti-TNF · 1

2012The Journal of rheumatologyPubMed

Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials

Épidémiologie & registres · 1

2024The Journal of infectionPubMed

Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry

IRM ostéo-articulaire · 1

2011Rheumatology (Oxford, England)PubMed

JAK inhibiteurs · 1

2023Rheumatology (Oxford, England)PubMed

JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Polymyalgia rheumatica · 1

2017Annals of the rheumatic diseasesPubMed

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

Recommandations · 1

2013Joint bone spinePubMed

Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health

Risque cardio-vasculaire · 1

2016Clinical and experimental rheumatologyPubMed

Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study

Dr Gael MouterdeRhumatologue à Montpellier

Lieux de consultation

Préparer votre rendez-vous

Conventionnement et remboursement

Expertise et points clés

Parcours et diplômes (9)

Travaux scientifiques (56)

Questions fréquentes sur Dr Gael Mouterde

Où consulte Dr Gael Mouterde ?

Comment prendre rendez-vous avec Dr Gael Mouterde ?

Dr Gael Mouterde est-il conventionné ?

Dr Gael Mouterde accepte-t-il la carte Vitale ?

D'où viennent les informations de cette page ?

Rhumatologues à Montpellier et alentours